UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of June 2026
Commission
File Number 001-15170
GSK plc
(Translation
of registrant’s name into English)
79 New Oxford Street, London, WC1A 1DG
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc (the
‘Company’)
Transaction notification
1.
Details of PDMR/person closely associated with them
(‘PCA’)
a)
Name
Sir Jonathan Symonds
b)
Position/status
Non-Executive Chair
c)
Initial
notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
a)
Description
of the financial instrument
Ordinary shares of 31 ¼ pence each (‘Ordinary
Shares’)
ISIN: GB00BN7SWP63
b)
Nature
of the transaction
Purchase of 1,550 Ordinary Shares
c)
Price(s)
and volume(s)
Price(s)
Volume(s)
£19.3524
1,550
d)
Aggregated
information
N/A (single transaction)
Aggregated volume
Price
e)
Date
of the transaction
2026-06-19
f)
Place
of the transaction
London Stock Exchange (XLON)
1.
Details of PDMR/person closely associated with them
(‘PCA’)
a)
Name
Elizabeth (Liz) McKee Anderson
b)
Position/status
Independent Non-Executive Director
c)
Initial
notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
a)
Description
of the financial instrument
American Depositary Shares (‘ADS’)
ISIN: US37733W2044
b)
Nature
of the transaction
Purchase of 789 ADS
c)
Price(s)
and volume(s)
Price(s)
Volume(s)
$50.6908
789
d)
Aggregated
information
N/A (single transaction)
Aggregated
volume
Price
e)
Date
of the transaction
2026-06-22
f)
Place
of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them
(‘PCA’)
a)
Name
Charles Bancroft
b)
Position/status
Senior Independent Non-Executive Director
c)
Initial
notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
a)
Description
of the financial instrument
American Depositary Shares (‘ADS’)
ISIN: US37733W2044
b)
Nature
of the transaction
Purchase of 1,855 ADS
c)
Price(s)
and volume(s)
Price(s)
Volume(s)
$50.6908
1,855
d)
Aggregated
information
N/A (single transaction)
Aggregated
volume
Price
e)
Date
of the transaction
2026-06-22
f)
Place
of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them
(‘PCA’)
a)
Name
Dr Anne Beal
b)
Position/status
Independent Non-Executive Director
c)
Initial
notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
a)
Description
of the financial instrument
American Depositary Shares (‘ADS’)
ISIN: US37733W2044
b)
Nature
of the transaction
Purchase of 745 ADS
c)
Price(s)
and volume(s)
Price(s)
Volume(s)
$50.6908
745
d)
Aggregated
information
N/A (single transaction)
Aggregated
volume
Price
e)
Date
of the transaction
2026-06-22
f)
Place
of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them
(‘PCA’)
a)
Name
Dr Hal Dietz
b)
Position/status
Independent Non-Executive Director
c)
Initial
notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
a)
Description
of the financial instrument
American Depositary Shares (‘ADS’)
ISIN: US37733W2044
b)
Nature
of the transaction
Purchase of 667 ADS
c)
Price(s)
and volume(s)
Price(s)
Volume(s)
$50.6908
667
d)
Aggregated
information
N/A (single transaction)
Aggregated
volume
Price
e)
Date
of the transaction
2026-06-22
f)
Place
of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them
(‘PCA’)
a)
Name
Dr Jeannie Lee
b)
Position/status
Independent Non-Executive Director
c)
Initial
notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
a)
Description
of the financial instrument
American Depositary Shares (‘ADS’)
ISIN: US37733W2044
b)
Nature
of the transaction
Purchase of 802 ADS
c)
Price(s)
and volume(s)
Price(s)
Volume(s)
$50.6908
802
d)
Aggregated
information
N/A (single transaction)
Aggregated
volume
Price
e)
Date
of the transaction
2026-06-22
f)
Place
of the transaction
New York Stock Exchange (XNYS)
1.
Details of PDMR/person closely associated with them
(‘PCA’)
a)
Name
Dr Vishal Sikka
b)
Position/status
Independent Non-Executive Director
c)
Initial
notification/amendment
Initial notification
2.
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a)
Name
GSK plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
a)
Description
of the financial instrument
American Depositary Shares (‘ADS’)
ISIN: US37733W2044
b)
Nature
of the transaction
Purchase of 1,266 ADS
c)
Price(s)
and volume(s)
Price(s)
Volume(s)
$50.6908
1,266
d)
Aggregated
information
N/A (single transaction)
Aggregated
volume
Price
e)
Date
of the transaction
2026-06-22
f)
Place
of the transaction
New York Stock Exchange (XNYS)
About GSK
GSK is a global biopharma company with a purpose to unite science,
technology, and talent to get ahead of disease together. Find out
more at www.gsk.com.
Registered in England & Wales:
No. 3888792
Registered Office:
79 New Oxford Street
London
WC1A 1DG
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
GSK plc
(Registrant)
Date: June
23, 2026
By:/s/ VICTORIA
WHYTE
————————–
Victoria Whyte
Authorised
Signatory for and on
behalf
of GSK plc